CNXU:NASDAQ, Conexeu Sciences Inc.

Why CNXU stock fell on November 20

Conexeu Sciences Inc. fell 25.5% on Friday, November 20, 2026, on 682,741 shares, 2.4 times its average daily volume. The headline around the move:

CNXU stock overview

Conexeu Sciences Inc. (CNXU:NASDAQ) closed at $1.55 on November 20, 2026, down 25.48% on the day. The stock trades 91.8% below its 52-week high of $18.79 and 4.7% above its 52-week low of $1.48. Over the past year, it lost 88.1%. Conexeu Sciences Inc. is part of the Health Care sector.

Key figures

Price
$1.55
Day change
-25.48%
Volume
682,741
Average volume
285,967
Market cap
47M+
52-week range
$1.48 – $18.79
50-day average
$3.29
200-day average
$7.31

Price action over the past year

In 127 trading sessions since May 22, 2026, CNXU closed higher on 48 days (38%). Its best day was June 16, 2026 (+27.49%) and its worst was November 20, 2026 (-25.48%). The stock moved 10% or more in a single session 29 times. It opened at least 5% above the previous day's high 3 times.

Recent signals

CNXU news

About Conexeu Sciences Inc.

Conexeu Sciences is a preclinical-stage regenerative tissue platform company. Our patented bioregenerative extracellular matrix (ECM) platform, CXU¿, is built on a single structural principle: one formula, one device, designed to scale across multiple addressable markets without reformulation. CXU¿ is designed to restore soft tissue lost through injury, aging, and GLP-1-associated tissue related weight loss. The Company's lead product, Ten Minute Tissue¿, is a CXU-based injectable ECM that remains fluid at room temperature and transitions to a stable gel in situ at body temperature within approximately ten minutes. In preclinical studies, Ten Minute Tissue¿ has demonstrated enhanced healing dynamics, organized scaffold formation, and a favorable (low) inflammatory profile, collectively supporting cell migration, proliferation, differentiation, and new tissue formation.

Similar stocks

Find more stocks like CNXU with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.